Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surplus protein myopathies.

H H Goebel1, I A Warlo

  • 1Department of Neuropathology, Johannes Gutenberg University Medical Center, Langenbeckstrasse 1, D-55131, Mainz, Germany. hgoebel@mail.zdv.uni-mainz.de

Neuromuscular Disorders : NMD
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog.

Molecular genetics and metabolism·2016
Same author

Protein aggregation in inclusion body myositis, a sporadic form among protein aggregate myopathies, and in myofibrillar myopathies--a comparative study.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2011
Same author

Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.

Neuropediatrics·2010
Same author

CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL.

Neurology·2010
Same author

Macrophagic myofasciitis plus (distinct types of muscular dystrophy).

Neuropediatrics·2010
Same author

Consequences of mutations within the C terminus of the FHL1 gene.

Neurology·2009
Same journal

Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.

Neuromuscular disorders : NMD·2026
Same journal

A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment.

Neuromuscular disorders : NMD·2026
Same journal

Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.

Neuromuscular disorders : NMD·2026
Same journal

Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study.

Neuromuscular disorders : NMD·2026
Same journal

HACD1-related congenital myopathy skeletal muscle MRI findings in a Brazilian cohort.

Neuromuscular disorders : NMD·2026
Same journal

Sensory abnormalities and entrapment neuropathies identified by nerve conduction studies in patients with amyotrophic lateral sclerosis.

Neuromuscular disorders : NMD·2026
See all related articles

Certain muscular dystrophies involve protein deficiency, while others feature excess proteins like desmin or actin. Further research is needed to understand these diverse surplus protein myopathies.

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Background:

  • Muscular dystrophies can result from absent/reduced proteins (e.g., dystrophinopathies) or surplus proteins.
  • Emerging congenital myopathies are characterized by granular or filamentous protein aggregates.

Purpose of the Study:

  • To explore the clinical, immunohistochemical, and genetic diversity of congenital myopathies characterized by surplus proteins.
  • To identify specific genes and proteins involved in these emerging myopathies.

Main Methods:

  • Immunohistochemistry to identify protein aggregates and related proteins.
  • Genetic analysis to detect mutations in implicated genes.

Main Results:

  • Desminopathies linked to mutations in desmin and alpha-B crystallin genes.

Related Experiment Videos

  • Actinopathy associated with actin gene mutations.
  • Nemaline bodies related to mutations in tropomyosin-3, actin, and nebulin genes.

    • Conclusions:

    • Congenital myopathies with surplus proteins are diverse clinically and genetically.
    • Identification of specific gene mutations provides insights into disease mechanisms.
    • Further investigation is crucial for understanding these emerging myopathies.